Anti-ZFP36L1 (phospho S92) antibody [EPR19926] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal ZFP36L1 phospho S92 antibody. Carrier free. Suitable for Dot, WB and reacts with Synthetic peptide - Human, Mouse, Human samples.
View Alternative Names
BERG36, BRF1, ERF1, RNF162B, TIS11B, ZFP36L1, mRNA decay activator protein ZFP36L1, Butyrate response factor 1, EGF-response factor 1, TPA-induced sequence 11b, ERF-1, ZFP36-like 1
- WB
Lab
Western blot - Anti-ZFP36L1 (phospho S92) antibody [EPR19926] - BSA and Azide free (AB238459)
Blocking and diluting buffer and concentration : 3% NFDM/TBST.
Lysates from the ZFP36L1fl/fl CD4 cre KO mouse were kindly provided by Dr Fiamma Salerno, Turner Lab, Babraham Institute.
Lysates used for the WB were isolated by negative selection using biotinylated abs against Ter119, CD11b, CD11c, Gr1, CD19, B220, F4/80 and NK1.1 to leave a population of CD4 and CD8 positive T cells (the purity of the population was >95% as checked by flow).
Mouse anti-vinculin ab130007, used as the loading control.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol and sodium azide (ab204922).
All lanes:
Western blot - Anti-ZFP36L1 (phospho S92) antibody [EPR19926] (<a href='/en-us/products/primary-antibodies/zfp36l1-phospho-s92-antibody-epr19926-ab204922'>ab204922</a>) at 1/2500 dilution
Lane 1:
Unstimulated wild-type mouse CD4+ and CD8+ T cells, whole cell lysate (Untreated membrane) at 20 µg
Lane 2:
Wild-type mouse CD4+ and CD8+ T cells treated with 10ng/ml Phorbol-12-myristate-13-acetate (PMA) and 1mM Ionomycin for 3 hours, whole cell lysate (Untreated membrane) at 20 µg
Lane 3:
Unstimulated ZFP36L1 knockout mouse CD4+ and CD8+ T cells, whole cell lysate (Untreated membrane) at 20 µg
Lane 4:
ZFP36L1 knockout mouse CD4+ and CD8+ T cells treated with 10ng/ml Phorbol-12-myristate-13-acetate (PMA) and 1mM Ionomycin for 3 hours, whole cell lysate (Untreated membrane) at 20 µg
Lane 5:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate (Untreated membrane) at 20 µg
Lane 6:
Unstimulated wild-type mouse CD4+ and CD8+ T cells, whole cell lysate (Phosphatase treated membrane) at 20 µg
Lane 7:
Wild-type mouse CD4+ and CD8+ T cells treated with 10ng/ml Phorbol-12-myristate-13-acetate (PMA) and 1mM Ionomycin for 3 hours, whole cell lysate (Phosphatase treated membrane) at 20 µg
Lane 8:
Unstimulated ZFP36L1 knockout mouse CD4+ and CD8+ T cells, whole cell lysate (Phosphatase treated membrane) at 20 µg
Lane 9:
ZFP36L1 knockout mouse CD4+ and CD8+ T cells treated with 10ng/ml Phorbol-12-myristate-13-acetate (PMA) and 1mM Ionomycin for 3 hours, whole cell lysate (Phosphatase treated membrane) at 20 µg
Lane 10:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate, (Phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>); and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/15000 dilution
Predicted band size: 36 kDa
Observed band size: 36-47 kDa
false
- Dot
Unknown
Dot Blot - Anti-ZFP36L1 (phospho S92) antibody [EPR19926] - BSA and Azide free (AB238459)
Dot blot analysis of ZFP36L1 (phospho S92) labeled with ab204922 at 1/1000 dilution.
Lane 1 : ZFP36L1 (phospho S92) peptide (aa87-97).
Lane 2 : ZFP36L1 non-phospho peptide (aa87-97).
Lane 3 : ZFP36L1 (phospho S125) peptide (aa120-130).
Lane 4 : ZFP36L1 non-phospho peptide (aa120-130).
Blocking and dilution buffer : 5% NFDM/TBST.Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Exposure time : 3 minutes.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol and sodium azide (ab204922).
Reactivity data
Product details
ab238459 is the carrier-free version of ab204922.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZFP36L1 acts as a post-transcriptional regulator of gene expression. It destabilizes mRNAs leading to their decay and reduced translation into proteins. While ZFP36L1 often functions as a monomer it can also form complexes with other proteins involved in RNA metabolism. As a result ZFP36L1 plays a critical role in the turnover of pro-inflammatory cytokines and growth factors impacting cellular responses to external stimuli. This regulatory function is essential for maintaining normal cellular homeostasis under various physiological conditions.
Pathways
ZFP36L1 integrates into signaling pathways such as MAPK and NF-kB which are important for inflammation and cellular stress responses. Within these pathways ZFP36L1 interacts with other signaling molecules like MK2 and p38 kinase. These interactions help mediate ZFP36L1's role in mRNA decay influencing the expression of genes involved in the immune response and cell survival. Its participation in these pathways highlights the regulatory landscape in which ZFP36L1 operates affecting diverse cellular functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com